Page 24 - Cassava Sciences News Today

/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that...

Cassava Sciences, Inc has filed a motion to dismiss the consolidated class action securities fraud case against it. The plaintiffs allege that Cassava

Small-cap stocks are usually young companies that aspire to become large-cap or mega-cap one day. Thus, choosing the right small-cap stocks can offer

/PRNewswire/ -- Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimers disease, (AD) which is estimated to...

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 20, 2022 /PRNewswire/ -- Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer's

We have used the September return data from finviz.com to rank the five best and worst performing small-cap stocks in September 2022.

Alzheimer's is one of the largest unmet medical needs. Today, there are 139 drugs in clinical trials for Alzheimer's. Click here to read more.

Alzheimer’s Patients Who Complete Participation in a Phase 3 Study of Simufilam are Eligible to Enroll52-week Study of Simufilam 100 mgUp to 1,600 Patients...

Aristides Capital’s long-short funds are down around 4.5 percent this year.

Should you buy Cassava Sciences (NASDAQ:SAVA) as the stock continues to soar? Retail interest in Cassava Sciences stock.